Resource Center
Resource Center
CHAI is proud to join the International Decision Support Initiative (iDSI). iDSI is a global network of health, policy and economic experts supporting low- and middle-income countries to make healthcare investment decisions that reflect the best value-for-money. CHAI is one of several partners who will expand the group’s global network of expertise and cross-country experience....
Read more
Sitting and talking with other people living with HIV at a health facility in Uganda, Zane* no longer felt alone. Unlike many of the others there who remained on efavirenz (EFV), he had recently switched to a new treatment regimen that includes dolutegravir (DTG) and could not believe how much better he felt. On DTG,...
Read more
This World AIDS Day, we celebrate the tremendous progress that has been made in response to the HIV/AIDS epidemic, with more than 20 million people living with HIV accessing life-saving antiretroviral treatment (ART) as of today. The incredible scale up of ART in developing countries, with affordable generic drugs widely available and the majority of...
Read more
Six countries in southern Africa – Botswana, Mozambique, Namibia, South Africa, Swaziland and Zimbabwe – are on the path towards malaria elimination, having declared their goal to achieve zero locally acquired malaria cases by 2020. The population at risk of the devastating illness in these countries has declined dramatically in recent years, with cases in...
Read more
South Africa has the third-highest Tuberculosis (TB) burden and the second-highest drug-resistant TB (DR-TB) burden globally. TB is a curable and preventable disease caused by bacteria spread from person to person through the air. Resistant forms of the disease pose a significant threat to preventing and treating further transmissions. Innovative approaches to expand the use...
Read more
HIV viral load testing improves the quality of care for patients on antiretroviral therapy. CHAI partnered with the Government of South Africa, UNAIDS, PEPFAR, Global Fund to Fight AIDS, Tuberculosis and Malaria, and Roche to negotiate a global access price for viral load of US$9.40 per test, which will save more than US$150 million between...
Read more